Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 233

1.

Autoimmune septin-5 cerebellar ataxia.

Honorat JA, Lopez-Chiriboga AS, Kryzer TJ, Fryer JP, Devine M, Flores A, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jul 9;5(5):e474. doi: 10.1212/NXI.0000000000000474. eCollection 2018 Sep.

PMID:
29998156
2.

Autoimmune GFAP astrocytopathy: Prospective evaluation of 90 patients in 1 year.

Dubey D, Hinson SR, Jolliffe EA, Zekeridou A, Flanagan EP, Pittock SJ, Basal E, Drubach DA, Lachance DH, Lennon VA, McKeon A.

J Neuroimmunol. 2018 Aug 15;321:157-163. doi: 10.1016/j.jneuroim.2018.04.016. Epub 2018 Apr 27.

PMID:
29793728
3.

Elevated LGI1-IgG CSF index predicts worse neurological outcome.

Gadoth A, Zekeridou A, Klein CJ, Thoreson CJ, Majed M, Dubey D, Flanagan EP, McKeon A, Jenkins SM, Lennon VA, Pittock SJ.

Ann Clin Transl Neurol. 2018 Apr 2;5(5):646-650. doi: 10.1002/acn3.561. eCollection 2018 May.

4.

Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Autoantibody Status Predict Outcome of Recurrent Optic Neuritis.

Jitprapaikulsan J, Chen JJ, Flanagan EP, Tobin WO, Fryer JP, Weinshenker BG, McKeon A, Lennon VA, Leavitt JA, Tillema JM, Lucchinetti C, Keegan BM, Kantarci O, Khanna C, Jenkins SM, Spears GM, Sagan J, Pittock SJ.

Ophthalmology. 2018 Apr 28. pii: S0161-6420(18)30240-9. doi: 10.1016/j.ophtha.2018.03.041. [Epub ahead of print]

PMID:
29716788
5.

Novel Glial Targets and Recurrent Longitudinally Extensive Transverse Myelitis.

Jitprapaikulsan J, Lopez Chiriboga AS, Flanagan EP, Fryer JP, McKeon A, Weinshenker BG, Pittock SJ.

JAMA Neurol. 2018 Jul 1;75(7):892-895. doi: 10.1001/jamaneurol.2018.0805. No abstract available.

PMID:
29710213
6.

Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.

Guerra H, Pittock SJ, Moder KG, Fryer JP, Gadoth A, Flanagan EP.

Mayo Clin Proc. 2018 Apr 11. pii: S0025-6196(18)30103-4. doi: 10.1016/j.mayocp.2018.02.006. [Epub ahead of print]

PMID:
29655487
7.

Reply to "epidemiology of autoimmune versus infectious encephalitis".

Dubey D, Pittock SJ, Toledano M, Flanagan EP.

Ann Neurol. 2018 May;83(5):1038. doi: 10.1002/ana.25230. No abstract available.

PMID:
29637594
8.

GAD65 autoantibody characteristics in patients with co-occurring type 1 diabetes and epilepsy may help identify underlying epilepsy etiologies.

Liimatainen S, Honnorat J, Pittock SJ, McKeon A, Manto M, Radtke JR; T1D Exchange Biobank, Hampe CS.

Orphanet J Rare Dis. 2018 Apr 10;13(1):55. doi: 10.1186/s13023-018-0787-5.

9.

Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.

Chen JJ, Tobin WO, Majed M, Jitprapaikulsan J, Fryer JP, Leavitt JA, Flanagan EP, McKeon A, Pittock SJ.

JAMA Ophthalmol. 2018 Apr 1;136(4):419-422. doi: 10.1001/jamaophthalmol.2017.6757.

PMID:
29470571
10.

Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders.

Hinson SR, Lopez-Chiriboga AS, Bower JH, Matsumoto JY, Hassan A, Basal E, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2018 Jan 23;5(2):e438. doi: 10.1212/NXI.0000000000000438. eCollection 2018 Mar.

11.

CSF free light chain identification of demyelinating disease: comparison with oligoclonal banding and other CSF indexes.

Gurtner KM, Shosha E, Bryant SC, Andreguetto BD, Murray DL, Pittock SJ, Willrich MAV.

Clin Chem Lab Med. 2018 Jun 27;56(7):1071-1080. doi: 10.1515/cclm-2017-0901.

PMID:
29455184
12.

ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association.

Alfugham N, Gadoth A, Lennon VA, Komorowski L, Scharf M, Hinson S, McKeon A, Pittock SJ.

Neurol Neuroimmunol Neuroinflamm. 2017 Dec 8;5(1):e418. doi: 10.1212/NXI.0000000000000418. eCollection 2018 Jan. No abstract available.

13.

MRI findings in glutamic acid decarboxylase associated autoimmune epilepsy.

Fredriksen JR, Carr CM, Koeller KK, Verdoorn JT, Gadoth A, Pittock SJ, Kotsenas AL.

Neuroradiology. 2018 Mar;60(3):239-245. doi: 10.1007/s00234-018-1976-6. Epub 2018 Jan 20.

PMID:
29353399
14.

Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis.

Dubey D, Pittock SJ, Kelly CR, McKeon A, Lopez-Chiriboga AS, Lennon VA, Gadoth A, Smith CY, Bryant SC, Klein CJ, Aksamit AJ, Toledano M, Boeve BF, Tillema JM, Flanagan EP.

Ann Neurol. 2018 Jan;83(1):166-177. doi: 10.1002/ana.25131.

PMID:
29293273
15.

Calcium channel autoimmunity: Cerebellar ataxia and lambert-eaton syndrome coexisting.

Zalewski N, Lennon VA, Pittock SJ, Mckeon A.

Muscle Nerve. 2017 Dec 22. doi: 10.1002/mus.26053. [Epub ahead of print]

PMID:
29272039
16.

Composite ganglioside autoantibodies and immune treatment response in MMN and MADSAM.

Martinez-Thompson JM, Snyder MR, Ettore M, McKeon A, Pittock SJ, Roforth MM, Mandrekar J, Mauermann ML, Taylor BV, Dyck PJB, Windebank AJ, Klein CJ.

Muscle Nerve. 2018 Jun;57(6):1000-1005. doi: 10.1002/mus.26051. Epub 2018 Jan 26.

PMID:
29272035
17.

Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases.

Dubey D, Lennon VA, Gadoth A, Pittock SJ, Flanagan EP, Schmeling JE, McKeon A, Klein CJ.

Neurology. 2018 Jan 9;90(2):e103-e110. doi: 10.1212/WNL.0000000000004803. Epub 2017 Dec 8.

PMID:
29222126
18.

Optic Disc Edema in Glial Fibrillary Acidic Protein Autoantibody-Positive Meningoencephalitis.

Chen JJ, Aksamit AJ, McKeon A, Pittock SJ, Weinshenker BG, Leavitt JA, Morris PP, Flanagan EP.

J Neuroophthalmol. 2017 Nov 21. doi: 10.1097/WNO.0000000000000593. [Epub ahead of print]

PMID:
29210929
19.

Neuromyelitis optica spectrum disorders and pregnancy: Interactions and management.

Shosha E, Pittock SJ, Flanagan E, Weinshenker BG.

Mult Scler. 2017 Dec;23(14):1808-1817. doi: 10.1177/1352458517740215. Review.

PMID:
29154728
20.

Purkinje cell cytoplasmic antibody type I (anti-Yo): predictive of gastrointestinal adenocarcinomas in men.

Linnoila J, Guo Y, Gadoth A, Raghunathan A, Parks B, McKeon A, Lucchinetti CF, Lennon VA, Pittock SJ.

J Neurol Neurosurg Psychiatry. 2017 Nov 15. pii: jnnp-2017-316829. doi: 10.1136/jnnp-2017-316829. [Epub ahead of print] No abstract available.

PMID:
29142142
21.

Breast cancer-related paraneoplastic neurologic disease.

Murphy BL, Zalewski NL, Degnim AC, McKeon A, Flanagan EP, Pittock SJ, Habermann EB.

Breast Cancer Res Treat. 2018 Feb;167(3):771-778. doi: 10.1007/s10549-017-4566-0. Epub 2017 Nov 7.

PMID:
29116466
22.

B-cell-targeted therapies in relapsing forms of MS.

Dubey D, Forsthuber T, Flanagan EP, Pittock SJ, Stüve O.

Neurol Neuroimmunol Neuroinflamm. 2017 Oct 23;4(6):e405. doi: 10.1212/NXI.0000000000000405. eCollection 2017 Nov. Review.

23.

LGI1, CASPR2 and related antibodies: a molecular evolution of the phenotypes.

Binks SNM, Klein CJ, Waters P, Pittock SJ, Irani SR.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):526-534. doi: 10.1136/jnnp-2017-315720. Epub 2017 Oct 21. Review.

24.

Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS).

Tobin WO, Guo Y, Krecke KN, Parisi JE, Lucchinetti CF, Pittock SJ, Mandrekar J, Dubey D, Debruyne J, Keegan BM.

Brain. 2017 Sep 1;140(9):2415-2425. doi: 10.1093/brain/awx200.

PMID:
29050399
25.

PRES leading to the diagnosis of McArdle disease.

Martinez-Thompson JM, Pittock SJ, Milone M.

J Clin Neurosci. 2017 Dec;46:62-64. doi: 10.1016/j.jocn.2017.08.013. Epub 2017 Sep 5.

PMID:
28887083
26.

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients.

Honorat JA, Komorowski L, Josephs KA, Fechner K, St Louis EK, Hinson SR, Lederer S, Kumar N, Gadoth A, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2017 Jul 18;4(5):e385. doi: 10.1212/NXI.0000000000000385. eCollection 2017 Sep.

27.

Dacrystic seizures-a cry for help.

Gadoth A, Singh J, Britton JW, Flanagan EP, Pittock SJ.

Neurol Neuroimmunol Neuroinflamm. 2017 Jun 16;4(4):e372. doi: 10.1212/NXI.0000000000000372. eCollection 2017 Jul. No abstract available.

28.

Expanded phenotypes and outcomes among 256 LGI1/CASPR2-IgG-positive patients.

Gadoth A, Pittock SJ, Dubey D, McKeon A, Britton JW, Schmeling JE, Smith A, Kotsenas AL, Watson RE, Lachance DH, Flanagan EP, Lennon VA, Klein CJ.

Ann Neurol. 2017 Jul;82(1):79-92. doi: 10.1002/ana.24979.

PMID:
28628235
29.

Autoimmune Neurology of the Central Nervous System.

Tobin WO, Pittock SJ.

Continuum (Minneap Minn). 2017 Jun;23(3, Neurology of Systemic Disease):627-653. doi: 10.1212/CON.0000000000000487. Review.

PMID:
28570322
30.

Predictive models in the diagnosis and treatment of autoimmune epilepsy.

Dubey D, Singh J, Britton JW, Pittock SJ, Flanagan EP, Lennon VA, Tillema JM, Wirrell E, Shin C, So E, Cascino GD, Wingerchuk DM, Hoerth MT, Shih JJ, Nickels KC, McKeon A.

Epilepsia. 2017 Jul;58(7):1181-1189. doi: 10.1111/epi.13797. Epub 2017 May 26.

31.

Disruption of the leptomeningeal blood barrier in neuromyelitis optica spectrum disorder.

Asgari N, Flanagan EP, Fujihara K, Kim HJ, Skejoe HP, Wuerfel J, Kuroda H, Kim SH, Maillart E, Marignier R, Pittock SJ, Paul F, Weinshenker BG.

Neurol Neuroimmunol Neuroinflamm. 2017 Apr 21;4(4):e343. doi: 10.1212/NXI.0000000000000343. eCollection 2017 Jul.

32.

Diagnosis and management of spinal cord emergencies.

Flanagan EP, Pittock SJ.

Handb Clin Neurol. 2017;140:319-335. doi: 10.1016/B978-0-444-63600-3.00017-9. Review.

PMID:
28187806
33.

Pathogenic implications of cerebrospinal fluid barrier pathology in neuromyelitis optica.

Guo Y, Weigand SD, Popescu BF, Lennon VA, Parisi JE, Pittock SJ, Parks NE, Clardy SL, Howe CL, Lucchinetti CF.

Acta Neuropathol. 2017 Apr;133(4):597-612. doi: 10.1007/s00401-017-1682-1. Epub 2017 Feb 9.

34.

Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.

Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A.

Ann Neurol. 2017 Feb;81(2):298-309. doi: 10.1002/ana.24881.

PMID:
28120349
35.

Association of Extension of Cervical Cord Lesion and Area Postrema Syndrome With Neuromyelitis Optica Spectrum Disorder.

Dubey D, Pittock SJ, Krecke KN, Flanagan EP.

JAMA Neurol. 2017 Mar 1;74(3):359-361. doi: 10.1001/jamaneurol.2016.5441. No abstract available.

PMID:
28097302
36.

Microtubule-associated protein 1B: Novel paraneoplastic biomarker.

Gadoth A, Kryzer TJ, Fryer J, McKeon A, Lennon VA, Pittock SJ.

Ann Neurol. 2017 Feb;81(2):266-277. doi: 10.1002/ana.24872.

PMID:
28074593
37.

Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders.

Zalewski NL, Morris PP, Weinshenker BG, Lucchinetti CF, Guo Y, Pittock SJ, Krecke KN, Kaufmann TJ, Wingerchuk DM, Kumar N, Flanagan EP.

J Neurol Neurosurg Psychiatry. 2017 Mar;88(3):218-225. doi: 10.1136/jnnp-2016-314738. Epub 2016 Dec 2.

PMID:
27913626
38.

A comparison of tissue-based and recombinant protein-based assays for detecting PCA-Tr/DNER-IgG.

Alfugham N, Roforth M, Komorowski L, Ott A, Meyer W, Probst C, Lennon VA, Pittock SJ, McKeon A.

Neurol Neuroimmunol Neuroinflamm. 2016 Oct 28;3(6):e294. eCollection 2016 Dec. No abstract available.

39.

Autoantibody-Associated Central Nervous System Neurologic Disorders.

Linnoila J, Pittock SJ.

Semin Neurol. 2016 Aug;36(4):382-96. doi: 10.1055/s-0036-1585453. Epub 2016 Sep 19. Review.

PMID:
27643908
40.

Autoimmune Glial Fibrillary Acidic Protein Astrocytopathy: A Novel Meningoencephalomyelitis.

Fang B, McKeon A, Hinson SR, Kryzer TJ, Pittock SJ, Aksamit AJ, Lennon VA.

JAMA Neurol. 2016 Nov 1;73(11):1297-1307. doi: 10.1001/jamaneurol.2016.2549.

PMID:
27618707
41.

Clinical-pathologic correlations in voltage-gated Kv1 potassium channel complex-subtyped autoimmune painful polyneuropathy.

Lahoria R, Pittock SJ, Gadoth A, Engelstad JK, Lennon VA, Klein CJ.

Muscle Nerve. 2017 Apr;55(4):520-525. doi: 10.1002/mus.25371. Epub 2017 Feb 13.

PMID:
27511450
42.

Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians.

Majed M, Fryer JP, McKeon A, Lennon VA, Pittock SJ.

Neurol Neuroimmunol Neuroinflamm. 2016 Apr 20;3(3):e231. doi: 10.1212/NXI.0000000000000231. eCollection 2016 Jun.

43.

Preface.

Pittock SJ, Vincent A.

Handb Clin Neurol. 2016;133:ix. doi: 10.1016/B978-0-444-63432-0.09991-6. No abstract available.

PMID:
27112695
44.

Current and future immunotherapy targets in autoimmune neurology.

Hu MY, Stathopoulos P, O'connor KC, Pittock SJ, Nowak RJ.

Handb Clin Neurol. 2016;133:511-36. doi: 10.1016/B978-0-444-63432-0.00027-X. Review.

PMID:
27112694
45.

Autoimmune AQP4 channelopathies and neuromyelitis optica spectrum disorders.

Hinson SR, Lennon VA, Pittock SJ.

Handb Clin Neurol. 2016;133:377-403. doi: 10.1016/B978-0-444-63432-0.00021-9. Review.

PMID:
27112688
46.

Paraneoplastic and idiopathic autoimmune neurologic disorders: approach to diagnosis and treatment.

Pittock SJ, Palace J.

Handb Clin Neurol. 2016;133:165-83. doi: 10.1016/B978-0-444-63432-0.00010-4.

PMID:
27112677
47.

Introduction to autoimmune neurology.

Pittock SJ, Vincent A.

Handb Clin Neurol. 2016;133:3-14. doi: 10.1016/B978-0-444-63432-0.00001-3. Review.

PMID:
27112668
48.

Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum.

Flanagan EP, Cabre P, Weinshenker BG, St Sauver J, Jacobson DJ, Majed M, Lennon VA, Lucchinetti CF, McKeon A, Matiello M, Kale N, Wingerchuk DM, Mandrekar J, Sagen JA, Fryer JP, Borders Robinson A, Pittock SJ.

Ann Neurol. 2016 Feb 17. doi: 10.1002/ana.24617. [Epub ahead of print]

49.

Metabotropic glutamate receptor type 1 autoimmunity: Clinical features and treatment outcomes.

Lopez-Chiriboga AS, Komorowski L, Kümpfel T, Probst C, Hinson SR, Pittock SJ, McKeon A.

Neurology. 2016 Mar 15;86(11):1009-13. doi: 10.1212/WNL.0000000000002476. Epub 2016 Feb 17.

50.

Demyelinating disease: NMO spectrum disorders: clinical or molecular classification?

Pittock SJ.

Nat Rev Neurol. 2016 Mar;12(3):129-30. doi: 10.1038/nrneurol.2016.9. Epub 2016 Feb 5. No abstract available.

PMID:
26846455

Supplemental Content

Loading ...
Support Center